Atorvastatin & Ovarian insufficiency

Effectiveness of atrovastatin on endometriosis women with poor ovarian response

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N47

Enrollment

Registered

2024-10-04

Start date

2024-10-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis with poor ovarian response. Endometriosis of ovary

Interventions

Intervention 1: Intervention group: Atrovastatin 10 mg daily for 3 months will be started then ovarian response evaluated . Intervention 2: Control group: Previous cycle of each patient is considered

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Abnormal ovarian reserve test Antral follicle count <5 At least one previous IVF cycle <3 oocyte was retrieved.

Exclusion criteria

Exclusion criteria: Ovarian insufficiency due to gonadal dysgenesia Abnormality of chromosoms Male infertility

Design outcomes

Primary

Measure	Time frame
AMH. Timepoint: Three months after intervention. Method of measurement: Blood test.;Oocyte number. Timepoint: Three months after intervention. Method of measurement: Oocyte number after OPU.;FSH. Timepoint: Three months after intervention. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026